HEDIS® Results

Medicaid HEDIS® Annual Rates.

Molina’s scores for the past two years are below. You can see how Molina performs compared to our target goal.

Measure

2021

2022

Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

72.98%

64.13%

64.52%

Annual Dental Visits (ADV) Total

NB

NB

53.67%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

36.07%

32.40%

46.09%

Appropriate Testing for Pharyngitis (CWP)

82.47%

71.59%

74.02%

Appropriate Treatment for Upper Respiratory Infection (URI)

85.39%

88.16%

92.46%

Asthma Medication Ratio (AMR) Total

64.50%

63.15%

68.21%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

47.72%

50.11%

58.74%

Breast Cancer Screening (BCS)

57.64%

53.25%

53.96%

Cervical Cancer Screening (CCS)

58.15%

62.53%

60.83%

Childhood Immunization Status (CIS) Combination #10

32.12%

25.79%

39.42%

Chlamydia Screening in Women (CHL) Total

59.16%

57.78%

60.24%

Comprehensive Diabetes Care (CDC) BP Control <140/90

60.34%

64.72%

65.21%

Comprehensive Diabetes Care (CDC) HbA1c Control <8.0%

44.77%

46.23%

52.80%

Comprehensive Diabetes Care (CDC) Eye Exam

55.96%

56.45%

54.74%

Controlling High Blood Pressure (CBP)

47.45%

54.74%

63.50%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

74.31%

79.97%

81.21%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

11.59%

11.23%

16.16%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

38.55%

42.06%

45.35%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

39.70%

37.88%

42.75%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

28.96%

25.19%

37.86%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

66.34%

45.50%

55.40%

Immunizations for Adolescents (IMA) Combination #2

32.60%

28.95%

39.16%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Rate Total

11.54%

11.92%

16.57%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Total

25.98%

26.94%

39.29%

Pharmacotherapy for Opioid Use Disorder (POD) Total

24.28%

52.43%

33.15%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

70.38%

68.87%

74.76%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

82.88%

79.47%

87.83%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

92.12%

89.25%

≤ 94.44%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

92.70%

87.83%

87.83%

Prenatal and Postpartum Care (PPC) Postpartum Care

74.45%

75.67%

80.00%

Prenatal Immunization Status (PRS) Combination Rate

18.37%

13.89%

27.32%

Risk of Continued Opioid Use (COU) 31-Day Total

3.45%

2.83%

≤ 2.35%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

80.70%

82.32%

82.29%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

67.06%

59.68%

73.75%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

66.72%

66.58%

68.32%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

63.48%

55.51%

70.00%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

60.43%

54.50%

65.63%

Use of Imaging Studies for Low Back Pain (LBP)

68.74%

68.69%

76.82%

Use of Opioids at High Dosage (HDO)

2.69%

1.93%

≤ 2.65%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

2.04%

1.16%

≤ 0.90%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

73.24%

70.56%

82.73%

 

NA = Not Available Due to Small Denominator
NB = No Benefit
NR = Not Reported
NQ = Not Required
BR = Biased Rate